Canvas Wealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Canvas Wealth Advisors's ABBV Position: Q3 2026 in Review
Canvas Wealth Advisors reduced its AbbVie (ABBV) stake by 14% in Q3 2026, selling an estimated $92.3K and leaving 2,245 shares worth $653K. The position accounts for 0.09% of the portfolio, ranked #115.
Canvas Wealth Advisors first reported a position in ABBV in Q1 2021 and has held it in 17 quarters since. The position peaked at $656K in Q2 2026. 3,450 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Canvas Wealth Advisors held 2,245 shares of AbbVie worth $653K as of Q3 2026.
- Canvas Wealth Advisors sold 360 AbbVie shares in Q3 2026, an estimated $92.3K.
- AbbVie made up 0.09% of Canvas Wealth Advisors's portfolio in Q3 2026, its #115 holding.
- Canvas Wealth Advisors first reported a position in AbbVie in Q1 2021 and has held it in 17 quarters since.
- Canvas Wealth Advisors's AbbVie position peaked at $656K in Q2 2026.
- 3,450 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Canvas Wealth Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.